Table 6.
Multivariate analysis of the correlation between clinicopathological parameters and overall survival time of HCC patients.
| Covariates | HR | 95% CI for HR | P |
|---|---|---|---|
| Gender (Male vs. Female) | 0.828 | 0.460–1.491 | 0.529 |
| Age (≤60 vs. >60 cm) | 0.722 | 0.718–1.624 | 0.177 |
| Tumor size (≤5 vs. >5 cm) | 0.592 | 0.365–0.960 | 0.034 |
| HbsAg (negative vs. positive) | 1.998 | 1.000–3.989 | 0.050 |
| Cirrhosis (No vs. Yes) | 0.531 | 0.192–1.466 | 0.222 |
| Child-Pugh (A vs. B) | 0.745 | 0.253–2.192 | 0.593 |
| AFP (≤20 vs. >20 ng/ml) | 0.707 | 0.425–1.176 | 0.182 |
| Differentiation (Well/moderate vs. Poor and not) | 0.945 | 0.554–1.611 | 0.835 |
| TNM stage (stage I/II vs. III/IV) | 0.377 | 0.208–0.681 | 0.001 |
| RBP2 expression (negative vs. positive) | 0.414 | 0.211–0.812 | 0.010 |